By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Satori Pharmaceuticals 

2 Gill Street

Woburn  Massachusetts  01801-1721  U.S.A.
Phone: 781-491-0414 Fax: n/a



Company News
Satori Pharmaceuticals Shuts Down After Alzheimer Trial Failure 5/31/2013 9:30:25 AM
Data Underscore Promise of Satori Pharmaceuticals' Gamma-Secretase Modulator Program in Treatment of Alzheimer's Disease 7/19/2012 10:19:09 AM
Satori Pharmaceuticals to Present Data Highlighting Promise of Gamma-Secretase Modulators in Treatment of Alzheimer's Disease 7/11/2012 10:42:07 AM
Satori Pharmaceuticals Raises $15 Million in New Funding 2/23/2012 6:50:36 AM
Satori Pharmaceuticals Demonstrates its Approach to Modulating Gamma-Secretase Effective In Reducing Plaque-Forming Amyloid Beta Peptide 7/18/2011 6:05:17 AM
Satori Pharmaceuticals Adds Key Senior Members to its Leadership Team; Steven Holtzman Elected Chair of the Board of Directors; Jeff Jonker Appointed Chief Business Officer 4/27/2010 3:33:32 PM
Steven Holtzman Joins Satori Pharmaceuticals Board of Directors 9/3/2009 12:01:16 PM
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO 1/8/2009 6:34:10 AM